The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly-Reference-Cited by-同舟云学术

The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly

Published:2024-08-19 Issue: Volume: Page:
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

Sahin Serdar,Gundogdu Aycan,Nalbantoglu Ufuk,Karaca Zuleyha,Hacioglu Aysa,Urhan Muhammed Emre,Unluhizarci Kursad,Hora Mehmet,Tanrıverdi Elif Seren,Durcan Emre,Elbüken Gülsah,Dokmetas Hatice Sebile,Zuhur Sayid Shafi,Tanriover Necmettin,Türe Ugur,Kelestimur Fahrettin,Kadioglu Pinar^ORCID

Funder

Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11102-024-01444-6.pdf

Reference66 articles.

1. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152. https://doi.org/10.1210/er.2002-0022

2. Bogazzi F, Colao A, Rossi G et al (2013) Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur J Endocrinol 169(3):367–376. https://doi.org/10.1530/EJE-13-0166

3. Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179(1):59–71. https://doi.org/10.1530/EJE-18-0255

4. Ursell LK, Haiser HJ, Van Treuren W et al (2014) The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 146(6):1470–1476. https://doi.org/10.1053/j.gastro.2014.03.001

5. Morgan XC, Segata N, Huttenhower C (2013) Biodiversity and functional genomics in the human microbiome. Trends Genet 29(1):51–58. https://doi.org/10.1016/j.tig.2012.09.005